According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in gene therapy using ... pH found inside cells, demonstrating sufficient ...

Our independent appraisal committee has approved the use of gene editing therapy exagamglogene autotemcel (exa-cel) for use in the NHS in England, providing a potential cure for some people with ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.